Possible role of cyclooxygenase-2 inhibitors as anticancer agents

Veterinary Record

Volumn 162, Issue 5, 2008, Pages 159-161

  Boonsoda, S ^a   Wanikiat, P ^b  

^a MAHANAKORN UNIVERSITY OF TECHNOLOGY   (Thailand)

^b Mahidol University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 39749182826     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.162.5.159     Document Type: Article

References (36)

1. ARA, G. & TEICHER, B. A. (1996) Cyclooxygenase, lipoxygenase inhibitors in cancer therapy. Prostaglandins, Leukotrienses, and Essential Fatty Acids 54, 3-16
2. BEAM, S. L., RASSNICK, K. M., MOORE, A. S. & MCDONOUGH, S. P. (2003) An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 40, 496-500
3. BORIA, P. A., MURRY, D. J., BENNETT, P. F., GLICKMAN, N. W., SNYDER, P. W., MERKEL, B. L., SCHLITTLER, D. L., MUTSAERS, A. J., THOMAS, R. M. & KNAPP, D. W. (2004) Evaluation of cisplatin combined with Piroxicam for the treatment or oral malignant melanoma and oral squamous cell carcinoma in dogs. Journal of the American Veterinary Medical Association 224, 388-394
4. BOUTEMMINE, D., BOUCHARD, N., BOERBOOM, D., JONES, H. E., GOFF, A. K., DORÉ, M. & SIROIS, J. (2002) Molecular characterization of canine prostaglandin G/H synthase~2 and regulation of prostatic adenocarcinoma cells in vitro. Endocrinology 143, 1134-1143
5. CHAN, T A., MORIN, P. J., VOGELSTEIN, B. & KINZLER, K. W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proceedings of the National Academy of Science of the United States of America 95, 681-686
6. CHU, I., LLOYD, E L., TRIFAN, O. C., KNAPP, B. & RIZZO, M. T. (2003) Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer. Molecular Cancer Therapeutics 2, 1-7
7. DEMPKE, W., RIE, C., GROTHEY, A. & SCHMOLL, H. J. (2001) Cyclooxygenase-2: a novel target for cancer chemotherapy? Journal of Cancer Research and Clinical Oncology 127, 411-417
8. DORE, M., LANTHIER, I. & SIROIS, J. (2003) Cyclooxygenase-2 expression in canine mammary tumours. Veterinary Pathology 40, 207-212
9. FOSSLIEN, E. (2000a) Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Critical Reviews in Clinical Laboratory Sciences 5, 431-502
10. FOSSLIEN, E. (2000b) Molecular pathology of cyclooxygenase-2 in neoplasia. Annals of Clinical Laboratory Sciences 30, 3-21
11. HABIB, A., CREMINON, C., FROBERT, Y., FROBERT, Y., GRASSI, J., PRADELLES, P. & MACLOUF, J. (1993) Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. Journal of Biological Chemistry 268, 23448-23454
12. HERRY, C. J., MCCAW, D. L., TURNQUIST, S. E., TURNQUIST, S. E., TYLER, J. W., BRAVO, L., SHEAFOR, S., STRAW, R. C., DERNELL1W. S., MADEWELL, B. R., JORGENSEN, L., SCOTT, M. A., HIGGINBOTHAM, M. L. & CHUN, R. (2003) Clinical evaluation of mitoxantrone and Piroxicam in canine model of human invasive urinary bladder carcinoma. Clinical Cancer Research 9, 906-911
13. HSU, A. L., CHING, T. T., WANG, D. S., SONG, X., RANGNEKAR, V. M. & CHEN, C. S. (2000) The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. Journal of Biological Chemistry 275, 11397-11403
14. JONES, C. J. & BUDSBERG, S. C. (2000) Physiologic characteristics and clinical importance of the cyclooxygenase isoformed in dogs and cats. Journal of the American Veterinary Medical Association 5, 721-729
15. KHAN, K. N. M., KNAPP, D. W., DENICOLA, D. B. & HARRIS, R. K. (2000) Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. American Journal of Veterinary Research 61, 478-481
16. KHAN, K. N. M., STANFIELD, K. M., TRAJKOVIC, D. & KNAPP, D. W. (2001) Expression of cyclooxygenase-2 in canine renal cell carcinoma. Veterinary Pathology 38, 116-119
17. KNAPP, D. W., GLICKMAN, N. W., WIDMER, W. R., DENICOLA, D. B., ADAMS, L. G., KUCZEK, T., BONNEY, P. L., DEGORTARl, A. E., HAN, C. & GLICKMAN, L. T. (2000) Cisplatin versus cisplatin combined with Piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemotherapy and Pharmacology 46, 221-226
18. LIM, J. T., PIAZZA, G. A., HAN, E. K., DELOHERY, T. M., LI, H., FINN, T. S., BUTTYAN, R., YAMAMOTO, H., SPERL, G. J., BRENDEL, K., GROSS, P. H., PAMUKCU, R. & WEINSTEIN, I. B. (1999) Sulindac derivatives inhibit growth and apoptosis in human prostate cancer cell lines. Biochemical Pharmacology 58, 1097-1107
19. MCENTEE, M. F., CATES, I. M. & NEILSON, N. (2002) Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Veterinary Pathology 39, 428-436
20. MASFERRER, J. L., ZWEIFEL, B. S., SEIBERT, K. & NEEDLEMAN, P. (1990) Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. Journal of Clinical Investigation 86, 1375-1379
21. MOHAMMED, S. I., BENNET, P. E., CRAIG, B. A., GLICKMAN, N. W., MUTSAERS, A.J., SNYDER, P. W., WIDMER, W. R., DEGORTARI, A. E., BONNEY, P. L. & KNAPP, D. W. (2002) Effects of the cyclooxygenase inhibitor, piroxicam, on tumour response, apoptosis, and angiogenesis in canine model of human invasives urinary bladder. Cancer Research 62, 356-358
22. MOHAMMED, S. I., COFFMAN, K., GLICKMAN, N. W., HAYEK, M. G., WATERS, D. I., SCHLITTLER, D., DENICOLA, D. B. & KNAPP, D. W. (2001) Prostaglandin E2 concentrations in naturally occurring canine cancer. Prostaglandins, Leukotrienes and Essential Fatty Acids 64, 1-4
23. MOHAMMED, S. I., CRAIG, B. A., MUTSAERS, A. J., GLICKMAN, N. W., SNYDER, P. W., DEGORTARI, A. E., SCHLITTLER, D. L., COFFMAN, K. T., BONNEY, P. L. & KNAPP, D. W. (2003) Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumour response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Molecular Cancer Therapeutics 2, 183-188
24. MOHAMMED, S. I., KHAN, K. N., SELLER, R. S., HAYEK, M. G., DENICOLA, D. B., WU, L., BONNEY, P. L. & KNAPP, D. W (2004) Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins, Leukotrienes, and Essential Fatty Acids 70, 479-483
25. MUTSAERS, A. I., GLICKMAN, N. W., DENICOLA, D. B., WIDMER, W. R., BONNEY, P. L., HAHN, K. A. & KNAPP, D. W. (2002) Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs. Journal of the American Veterinary Medical Association 220, 1813-1817
26. MUTSAERS, A. J., MOHAMMED, S. I., DENICOLA, D. B., SNYDER, P. W., GLICKMAN, N. W., BENNETT, P. F., DE GORTARI, A. E., BONNEY, P. L. & KNAPP, D. W. (2005) Pretreatment tumour prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy. Prostaglandins, Leukotrienes, and Essential Fatty Acids 72, 181-186
27. O'SULLIVAN, M. G., CHILTON, F. H., HUGGINS, E. M., Jr & MCCALL, C. E. {1992) Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. Journal of Biological Chemistry 267, 14547-14550
28. PESTILI DE ALMEIDA, E. M., PICHE, C., SIROIS, J. & DORE, M. (2001) Expression of cyclooxygenase-2 in naturally occurring squamous cell carcinomas in dogs. Journal of Histochemistry and Cytochemistry 49, 867-875
29. RICCHI, P., ZARRILLI, R., DI PALMA, A. & ACQUAVIVA, A. M. (2003) Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. British Journal of Cancer 88, 803-807
30. SCHMIDT, B. R., GLICKMAN, N. W., DENICOLA, D. B., DE GORTARI, A. E. & KNAPP, D. W. (2001) Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. Journal of the American Veterinary Medical Association 218, 1783-1786
31. SHAHEEN, N. J., STRAUS, W. L. & SANDLER, R. S. (2002) Chemoprevention of gastrointestinal malignancies with nonsteroidal anti-inflammatory drugs. Cancer 94, 950-963
32. SONG, X., LIN, H. P., JOHNSON, A. J., TSENG, RH., YANG, Y. T., KULP, S. K. & CHEN, C. S. (2002) Cyclooxygenase-2, player and speculator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cell. Journal of the National Cancer Institute 94, 585-591
33. TAKETO, M. M. (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part II). Journal of the National Cancer Institute 90, 1609-1620
34. THUN, M. J., HENLEY, S. J. & PATRONO, C. (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. Journal of the National Cancer Institute 94, 252-266
35. TRIFAN, O. C., SMITH, R. M., THOMPSON, B. D. & HLA, T. (1999) Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence fora prostaglandin-independent mechanism. Journal of Biological Chemistry 274, 34141-34147
36. TSUJII, M., KAWANO, S. & DUBOIS, R. N. ( 1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proceedings of the National Academy of Sciences of the United States of America 94, 3336-3340